Harm reduction funding meeting only 7% of global need
Maraviroc fails to match tenofovir/emtricitabine for first-line HIV treatment
Meta-analysis: only half the people who start PEP complete the course
Globally, 1 in 12 MSM have been arrested for same-sex behaviour
Good adherence seen in study of intermittent PrEP
Novel techniques probed in cure research
Romidepsin activates latent HIV, but does not decrease viral reservoir
Adolescent deaths from AIDS rising, especially among boys
Reappearance of HIV in "Mississippi Baby" poses questions for early treatment